News Search results: Head and neck cancer
Three indications have been prioritized: Head and Neck cancer, Chronic Lymphocytic Leukemia and Ovarian cancer. · Sep. 18, 2014  Explore story »
Related News
The investigational drug alpelisib, previously known as BYL719, was able to overcome head and neck cancer resistance to the anti–EGFR treatment
MDLinx · Sep. 18, 2014
Alberta Health Services hopes this vaccine will prevent the more than 400 cases of head and neck cancer among men in the province.
CBC · Sep. 18, 2014
12 FHACT Test - Head and Neck Cancer 12 FHACT Test - Head and Neck Cancer Product Overview 12 FReCaD Renal Cancer Test 13 FReCaD Renal Cancer...
BioPortfolio · Sep. 19, 2014